Globus Medical Revenue and Competitors
Estimated Revenue & Valuation
- Globus Medical's estimated annual revenue is currently $941.5M per year.
- Globus Medical's estimated revenue per employee is $324,107
- Globus Medical's total funding is $128.5M.
- Globus Medical's current valuation is $7.5B. (January 2022)
Employee Data
- Globus Medical has 2905 Employees.
- Globus Medical grew their employee count by 6% last year.
Globus Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Accounting Officer | Reveal Email/Phone |
2 | Global VP, Human Resources | Reveal Email/Phone |
3 | Area VP Sales | Reveal Email/Phone |
4 | Area VP Sales | Reveal Email/Phone |
5 | CTO Imaging, Navigation & Robotics | Reveal Email/Phone |
6 | VP, Chief Patent Counsel | Reveal Email/Phone |
7 | VP US Sales- East | Reveal Email/Phone |
8 | VP, Surgical Navigation | Reveal Email/Phone |
9 | Administrative Assistant to the Chief Technology Officer Imaging, Navigation & Robotics | Reveal Email/Phone |
10 | SVP Professional Affairs | Reveal Email/Phone |
Globus Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1130M | 2832 | -8% | $65.3M | $2.9B |
#2 | $5490M | 9425 | 100% | N/A | $109.9B |
What Is Globus Medical?
Globus Medical, Inc. was founded in 2003 by a group of medical device professionals with a vision to create products that enable spine surgeons to employ both fusion and non-fusion solutions to promote healing in patients with spinal disorders. Today Globus is one of the fastest growing spinal implant companies in the world and a recognized leader in the development of motion sparing technology.
keywords:N/A
$128.5M
Total Funding
2905
Number of Employees
$941.5M
Revenue (est)
6%
Employee Growth %
$7.5B
Valuation
N/A
Accelerator
Globus Medical News
Globus develops products for patients with musculoskeletal disorders, with a primary focus on spinal care. The company offers traditional spinal...
Globus Medical specializes in designing, developing and manufacturing products from orthopedic implants to artificial joints that enable...
Globus Medical announced the unexpected resignation of CEO Dave Demski. The company also provided preliminary Q1 sales that were lower than...
AUDUBON, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that Excelsius3D™, an intelligent intraoperative 3-in-1 imaging system, has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) ...
Globus Medical (NYSE:GMED) said it acquired Transplant Technologies of Texas, a San Antonio-based provider of bone allografts, biomaterials and soft tissue products, for an unspecified amount. Transplant Technologies of Texas processes sterile human tissue and distributes allograft implants inc ...